Capsugel® Zephyr™ Technical Brief

Dry-powder inhalation capsules provide a maior drug development opportunity for pulmonary treatments and systemic applications. 

Lonza's Capsugel® Zephyr™ Dry-Powder Inhalation Capsule Portfolio offers the most complete portfolio of DPl capsules with targeted emitted dose that are tailored toward formulation properties and inhalation device. The high-quality customizable capsule solutions based on different polymers and compositions are supported by a wide range of services within Lonza. 


To View, Please Provide the Following

Access all of the latest news, white papers, webinars and knowledge center resources.